Target Validation
Unlock new therapeutic discoveries with a trusted Target Validation Platform
Securely connect, analyze, and validate multi-omic and clinical data to uncover disease mechanisms, identify biomarkers, and accelerate translational research—while maintaining full data control.
Unlock the power of federated target discovery, securely
Lifebit’s Target Validation Platform connects research institutions, pharma partners, and data custodians to analyze multi-omic and clinical data—without moving it or compromising privacy.
AI-Powered Target Discovery
Accelerate identification of novel therapeutic targets
Trusted TargetID, Lifebit’s Population Genomics AI Agent, runs GWAS, fine-mapping, colocalization, and Mendelian randomization across biobanks, then ranks targets you can trace back to the data.
Secure Federated Collaboration
Collaborate on sensitive data without moving it
At Boehringer Ingelheim, some target identification analyses that took months now run in 59 minutes, across 500,000+ UK Biobank and 100,000+ Genomics England participants. Data never leaves the source.
Translational Insights at Scale
Transform data into actionable biological insights
Link molecular findings to clinical outcomes. In The Lancet Oncology, a study of 2,445 breast cancers in the Genomics England environment run by Lifebit found 27% had features that could guide treatment.
Work Together
Great work doesn’t happen alone. Let our experts show you how our product suite eliminates silos and unifies strategy.
